{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:10:39Z","timestamp":1778245839601,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biopha.2017.11.103","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T02:35:09Z","timestamp":1512527709000},"page":"1513-1526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A review on the antagonist Ebola: A prophylactic approach"],"prefix":"10.1016","volume":"96","author":[{"given":"Fatima Nazish","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushnuma","family":"Tanveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2017.11.103_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2221-1691(15)30365-8","article-title":"Ebola virus disease: past, present and future","volume":"5","author":"Rajak","year":"2015","journal-title":"Asia. Pac. J. Trop. Biomed."},{"issue":"9768","key":"10.1016\/j.biopha.2017.11.103_bib0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.11.103_bib0015","series-title":"Imported Virus Infections","first-page":"77","article-title":"Emerging and reemerging of filoviruses","author":"Feldmann","year":"1996"},{"issue":"5\u20136","key":"10.1016\/j.biopha.2017.11.103_bib0020","first-page":"125","article-title":"Clinical development of Ebola vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Ther. Adv. Vacc."},{"issue":"18","key":"10.1016\/j.biopha.2017.11.103_bib0025","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.77.18.9733-9737.2003","article-title":"Ebola virus pathogenesis: implications for vaccines and therapies","volume":"77","author":"Sullivan","year":"2003","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.103_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1871526516666160108114644","article-title":"Ebola virus is altered innate and adaptive immune response signaling pathways: implications for novel therapeutic approaches","volume":"16","author":"Kumar","year":"2016","journal-title":"Infect. Disord.- Drug. Targets"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.103_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-8518-2-1","article-title":"Dendritic cells: in the forefront of immunopathogenesis and vaccine development\u2013A review","volume":"2","author":"Mohamadzadeh","year":"2004","journal-title":"J. Immune Based Therapies Vaccines"},{"key":"10.1016\/j.biopha.2017.11.103_bib0040","series-title":"Sierra Leone: Helping the Ebola Survivors Turn the Page","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.biopha.2017.11.103_bib0045","series-title":"2014 Ebola Outbreak in West Africa\u2014case Counts","author":"Centers for Disease Control and Prevention","year":"2014"},{"issue":"Supplement_1","key":"10.1016\/j.biopha.2017.11.103_bib0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients","volume":"179","author":"Bwaka","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.103_bib0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tim.2007.08.001","article-title":"The ecology of Ebola virus","volume":"15","author":"Groseth","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.biopha.2017.11.103_bib0060","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.biopha.2017.05.045","article-title":"Recent trends in ZikV research: A step away from cure","volume":"91","author":"Alam","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.11.103_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2017.02.006","article-title":"Ebola virus persistence as a new focus in clinical research","volume":"23","author":"Caviness","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.biopha.2017.11.103_bib0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.103_bib0075","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3201\/eid2209.151621","article-title":"Clinical features of and risk factors for fatal Ebola virus disease, Moyamba District, Sierra Leone, December 2014\u2013February 2015","volume":"22","author":"Haaskjold","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.103_bib0080","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/ciw158","article-title":"Ebola virus disease complications as experienced by survivors in sierra Leone","volume":"62","author":"Tiffany","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2017.11.103_bib0085","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","article-title":"Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study","volume":"15","author":"Clark","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.biopha.2017.11.103_bib0090","series-title":"Studies on Ebola Survivors Show Range of Complications. Center For Infectious Disease Research And Policy (CIDRAP) News","author":"Wappes","year":"2016"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.103_bib0095","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.aogh.2015.02.005","article-title":"Transmission of Ebola virus disease: an overview","volume":"80","author":"Rewar","year":"2014","journal-title":"Ann. Global Health"},{"key":"10.1016\/j.biopha.2017.11.103_bib0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-med-052915-015604","article-title":"Ebola: anatomy of an epidemic","volume":"68","author":"Lo","year":"2017","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.103_bib0105","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S1473-3099(16)00077-3","article-title":"Sequelae of Ebola virus disease: the emergency within the emergency","volume":"16","author":"Vetter","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2017.11.103_bib0110","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1126\/science.1175035","article-title":"Biodiversity conservation and the millennium development goals","volume":"325","author":"Sachs","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2017.11.103_bib0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/458579a","article-title":"Ecology: Gini in the bottle","volume":"458","author":"Naeem","year":"2009","journal-title":"Nature"},{"issue":"5656","key":"10.1016\/j.biopha.2017.11.103_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1126\/science.1090727","article-title":"Unifying the epidemiological and evolutionary dynamics of pathogens","volume":"303","author":"Grenfell","year":"2004","journal-title":"Science"},{"issue":"1604","key":"10.1016\/j.biopha.2017.11.103_bib0125","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1098\/rstb.2012.0228","article-title":"A framework for the study of zoonotic disease emergence and its drivers: spillover of bat pathogens as a case study","volume":"367","author":"Wood","year":"2012","journal-title":"Phil. Trans. R. Soc. B"},{"issue":"10","key":"10.1016\/j.biopha.2017.11.103_bib0130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1461-0248.2012.01836.x","article-title":"Model\u2010guided fieldwork: practical guidelines for multidisciplinary research on wildlife ecological and epidemiological dynamics","volume":"15","author":"Restif","year":"2012","journal-title":"Ecol. Lett."},{"issue":"7324","key":"10.1016\/j.biopha.2017.11.103_bib0135","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature09575","article-title":"Impacts of biodiversity on the emergence and transmission of infectious diseases","volume":"468","author":"Keesing","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.11.103_bib0140","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nbt0914-849a","article-title":"Biotech drugs too little, too late for Ebola outbreak","volume":"32","author":"Strauss","year":"2014","journal-title":"Nat. Bioechnol"},{"key":"10.1016\/j.biopha.2017.11.103_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in non human primates with Zmapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.11.103_bib0150","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nbt1207-1383","article-title":"Systems biology and the host response to viral infection","volume":"25","author":"Tan","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.103_bib0155","doi-asserted-by":"crossref","first-page":"e1005074","DOI":"10.1371\/journal.pcbi.1005074","article-title":"Systems biology-based investigation of cellular antiviral drug targets identified by gene-trap insertional mutagenesis","volume":"12","author":"Cheng","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.biopha.2017.11.103_bib0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.imu.2015.12.001","article-title":"Ebinformatics: Ebola fuzzy informatics systems on the diagnosis, prediction and recommendation of appropriate treatments for Ebola virus disease (EVD)","volume":"2","author":"Oluwagbemi","year":"2016","journal-title":"Inf. Med. Unlocked"},{"issue":"7181","key":"10.1016\/j.biopha.2017.11.103_bib0165","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.biopha.2017.11.103_bib0170","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.103_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543784.2017.1260545","article-title":"The early clinical development of Ebola virus treatments","volume":"26","author":"Bradfute","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.103_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7774\/cevr.2015.4.1.11","article-title":"Progress of vaccine and drug development for Ebola preparedness","volume":"4","author":"Choi","year":"2015","journal-title":"Clin. Exp. Vacc. Res."},{"issue":"9957","key":"10.1016\/j.biopha.2017.11.103_bib0185","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(14)62043-2","article-title":"First trials for Ebola treatments announced","volume":"384","author":"Mohammadi","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.103_bib0190","doi-asserted-by":"crossref","first-page":"e1001815","DOI":"10.1371\/journal.pmed.1001815","article-title":"Evaluating clinical trial designs for investigational treatments of ebola virus disease","volume":"12","author":"Cooper","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.biopha.2017.11.103_bib0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jcv.2016.11.005","article-title":"Ebola virus disease: an update on current prevention and management strategies","volume":"86","author":"Trad","year":"2017","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.103_bib0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrd1694","article-title":"The evolving field of biodefence: therapeutic developments and diagnostics","volume":"4","author":"Burnett","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2017.11.103_bib0205","first-page":"67","article-title":"Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives","volume":"3","author":"Olszanecki","year":"2014","journal-title":"Folia Med. Cracov."},{"issue":"Supplement_1","key":"10.1016\/j.biopha.2017.11.103_bib0210","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/514306","article-title":"The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995","volume":"179","author":"Khan","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2017.11.103_bib0215","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/infdis\/jix189","article-title":"Six-month safety data of recombinant vesicular stomatitis virus\u2013zaire ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebo-controlled randomized study in healthy adults","volume":"215","author":"Halperin","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"10068","key":"10.1016\/j.biopha.2017.11.103_bib0220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.biopha.2017.11.103_bib0225","first-page":"442","article-title":"Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis","volume":"72","author":"Goeijenbier","year":"2014","journal-title":"J. Med."},{"issue":"suppl_2","key":"10.1016\/j.biopha.2017.11.103_bib0230","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/infdis\/jiu681","article-title":"An improved reverse genetics system to overcome cell-type\u2013dependent ebola virus genome plasticity","volume":"212","author":"Tsuda","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"19","key":"10.1016\/j.biopha.2017.11.103_bib0235","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2015.03.029","article-title":"A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose","volume":"33","author":"Tsuda","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2017.11.103_bib0240","series-title":"A Long-Lasting, Single-Dose Nasal Vaccine for Ebola: a Practical Armament for an Outbreak With Significant Global Impact","author":"Jonsson-Schmunk","year":"2015"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.103_bib0245","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/viro.1998.9176","article-title":"DNA vaccines expressing either the GP or NP genes of ebola virus protect mice from lethal challenge","volume":"246","author":"Vanderzanden","year":"1998","journal-title":"Virology"},{"issue":"24","key":"10.1016\/j.biopha.2017.11.103_bib0250","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1073\/pnas.1316902111","article-title":"Vaccinating captive chimpanzees to save wild chimpanzees","volume":"111","author":"Warfield","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"suppl_3","key":"10.1016\/j.biopha.2017.11.103_bib0255","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant vesicular stomatitis virus\u2013based vaccines against Ebola and Marburg virus infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.103_bib0260","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4161\/hv.6.6.11097","article-title":"Recent advances in Ebolavirus vaccine development","volume":"6","author":"Richardson","year":"2010","journal-title":"Hum. Vaccin."},{"issue":"1721","key":"10.1016\/j.biopha.2017.11.103_bib0265","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0295","article-title":"A review of phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?","volume":"372","author":"Lambe","year":"2017","journal-title":"Phil. Trans. R. Soc. B"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.103_bib0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.virol.2010.02.029","article-title":"Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms","volume":"401","author":"Shedlock","year":"2010","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.103_bib0275","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40121-015-0079-5","article-title":"Ebola virus infection: overview and update on prevention and treatment","volume":"4","author":"Martin","year":"2015","journal-title":"Infect. Dis. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2017.11.103_bib0280","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/JVI.01456-10","article-title":"Identification of a small-molecule entry inhibitor for filoviruses","volume":"85","author":"Basu","year":"2011","journal-title":"J. Virol."},{"issue":"9729","key":"10.1016\/j.biopha.2017.11.103_bib0285","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.biopha.2017.11.103_bib0290","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.103_bib0295","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","article-title":"Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses","volume":"12","author":"Florescu","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"7496","key":"10.1016\/j.biopha.2017.11.103_bib0300","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biopha.2017.11.103_bib0305","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2471\/BLT.14.149278","article-title":"Health-system resilience: reflections on the Ebola crisis in western Africa","volume":"92","author":"Kieny","year":"2014","journal-title":"Bull. World Health Organ."},{"issue":"9980","key":"10.1016\/j.biopha.2017.11.103_bib0310","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/S0140-6736(15)60755-3","article-title":"What is a resilient health system? Lessons from Ebola","volume":"385","author":"Kruk","year":"2015","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.103_bib0315","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1037\/0003-066X.56.3.227","article-title":"Ordinary magic: resilience processes in development","volume":"56","author":"Masten","year":"2001","journal-title":"Am. Psychol."},{"key":"10.1016\/j.biopha.2017.11.103_bib0320","series-title":"The Resilience Dividend: Being Strong in a World Where Things Go Wrong. Public Affairs","author":"Rodin","year":"2014"},{"key":"10.1016\/j.biopha.2017.11.103_bib0325","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S0140-6736(14)61345-3","article-title":"Ebola: towards an international health systems fund","volume":"384","author":"Gostin","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.11.103_bib0330","series-title":"Resilience, Vulnerability, and Adaptive Capacity: Implications for System Performance","author":"Dalziell","year":"2004"},{"issue":"5737","key":"10.1016\/j.biopha.2017.11.103_bib0335","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.1111534","article-title":"Toward inherently secure and resilient societies","volume":"309","author":"Allenby","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biopha.2017.11.103_bib0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2017.03.003","article-title":"How to treat ebola virus infections? A lesson from the field","volume":"24","author":"Duraffour","year":"2017","journal-title":"Curr. Opin. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.103_bib0345","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.apjtb.2016.01.012","article-title":"Optimal control application to an Ebola model","volume":"6","author":"Bonyah","year":"2016","journal-title":"Asia. Pac. J. Trop. Biomed."},{"key":"10.1016\/j.biopha.2017.11.103_bib0350","series-title":"Mathematical Theory of Optimal Processes","author":"Pontryagin","year":"1987"},{"issue":"13","key":"10.1016\/j.biopha.2017.11.103_bib0355","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMp1409903","article-title":"Ebola 2014\u2014new challenges, new global response and responsibility","volume":"371","author":"Frieden","year":"2014","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.103_bib0360","first-page":"119","article-title":"Oligonucleotide, antibody and peptide therapeutics--from design to the clinic","volume":"6","author":"Goodchild","year":"2004","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.103_bib0365","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JVI.73.3.2333-2342.1999","article-title":"Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems","volume":"73","author":"M\u00fchlberger","year":"1999","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.103_bib0370","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"Towner","year":"2005","journal-title":"Virology"},{"issue":"9400","key":"10.1016\/j.biopha.2017.11.103_bib0375","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","article-title":"Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys","volume":"362","author":"Geisbert","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.biopha.2017.11.103_bib0380","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event","volume":"188","author":"Geisbert","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"suppl_3","key":"10.1016\/j.biopha.2017.11.103_bib0385","doi-asserted-by":"crossref","first-page":"S1043","DOI":"10.1093\/infdis\/jir345","article-title":"Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation","volume":"204","author":"Yen","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.103_bib0390","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1073\/pnas.89.11.4825","article-title":"The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase","volume":"89","author":"Chang","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2017.11.103_bib0395","first-page":"131","article-title":"Learning from our foes: a novel vaccine concept for influenza virus","author":"Palese","year":"1999","journal-title":"Arch. Virol. Suppl."},{"issue":"22","key":"10.1016\/j.biopha.2017.11.103_bib0400","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1073\/pnas.220398297","article-title":"The Ebola virus VP35 protein functions as a type I IFN antagonist","volume":"97","author":"Basler","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.103_bib0405","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.103_bib0410","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/1469-0691.12699","article-title":"Biological warfare, bioterrorism, and biocrime","volume":"20","author":"Jansen","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.biopha.2017.11.103_bib0415","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMp1502918","article-title":"The next epidemic- lessons from Ebola","volume":"372","author":"Gates","year":"2015","journal-title":"The New. Engl. J. Med."},{"key":"10.1016\/j.biopha.2017.11.103_bib0420","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1086\/514287","article-title":"Ebola hemorrhagic fever: lessons from Kikwit, Democratic Republic of Congo","volume":"179","author":"Heymann","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.103_bib0425","first-page":"70","article-title":"An outbreak of fear, rumours and stigma: psychosocial support for the Ebola virus disease outbreak in West Africa","volume":"13","author":"Cheung","year":"2015","journal-title":"Intervention"},{"issue":"6202","key":"10.1016\/j.biopha.2017.11.103_bib0430","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1259657","article-title":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak","volume":"345","author":"Gire","year":"2014","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.biopha.2017.11.103_bib0435","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1128\/JVI.00924-15","article-title":"Different temporal effects of Ebola virus VP35 and VP24 proteins on global gene expression in human dendritic cells","volume":"89","author":"Ilinykh","year":"2015","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.biopha.2017.11.103_bib0440","first-page":"144","article-title":"Ebola virus- symptomatology and intervention","volume":"1","author":"Lakshmi","year":"2013","journal-title":"Int. J. Bus. Admin. Res. Rev."},{"issue":"20","key":"10.1016\/j.biopha.2017.11.103_bib0445","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1128\/JVI.01736-15","article-title":"Suppressor of cytokine signaling 3 is an inducible host factor that regulates virus egress during Ebola virus infection","volume":"89","author":"Okumura","year":"2015","journal-title":"J. Virol."},{"issue":"25","key":"10.1016\/j.biopha.2017.11.103_bib0450","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"New Engl. J. Med."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.103_bib0455","doi-asserted-by":"crossref","first-page":"e1359","DOI":"10.1371\/journal.pntd.0001359","article-title":"Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression","volume":"5","author":"Wahl-Jensen","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.103_bib0460","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/AAC.01105-15","article-title":"Addressing therapeutic options for ebola virus infection in current and future outbreaks","volume":"59","author":"Haque","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217337502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217337502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:18:24Z","timestamp":1778242704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217337502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":92,"alternative-id":["S0753332217337502"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.103","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on the antagonist Ebola: A prophylactic approach","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}